In-phase (A) and opposed phase (B) chemical shift MR images of a 51-year-old male demonstrate hepatic steatosis, consistent with areas of decreased signal intensity on an opposed-p... by Andrzej Cieszanowski (635105)

Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production. by Bei Wang (116772)

NFκB-p50 knockdown decreases CD44 expression. by Shannon M. Smith (115335)

Effect of 5-HTR blockade on the relationship between error rate and reaction time in the reward-size task. by Yukiko Hori (299784)

Subjects:

IFNγ increases PRL immunoreactivity in the hair follicle, whilst TNFα decreases follicular PRL immunoreactivity. by Ewan A. Langan (405804)

“…Results were pooled from 3 ♀ subjects (Aged 44–68), 14–16 HFs per group in total. In contrast, TNFα 5 ng/ml significantly decreased PRL IR (E). PRL IR is shown in (F) control hair follicles and those treated with (G) TNFα 0.5 ng/ml and (H) TNFα 5 ng/ml. …”

Prevalence and anatomic level of stenosis ≥ 50% in either limb. by O. Stivalet (6890189)

Surface tension versus time of the MHS solution (50 mM) and LNC dispersion containing 50 mM MHS as determined by drop tensiometry. by Celia R. A. Mouzouvi (4347937)

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

SDG decreases iron-induced apoptosis in H9c2 cells. by Stephanie Puukila (568109)

Hyperalgesia was assessed by a decrease in paw withdrawal threshold (PWT_50%) in a model of mild heat injury (MHI). by Manuel P. Pereira (417488)

Figure 1 Exogenous serotonin inhibits the Dar phenotype and decreases pathogen clearance rates by Rachel Mcmullan (506214)

“…Treatment with 3.8mg/ml 5-HT caused a 35% decrease in the number of Dar animals following M. nematophilum infection using standard assay conditions (small lawn) (A). …”

LPLI decreases IκBα degradation and NFκB activation. by Jyun-Yi Wu (103136)

5-HT₇Dro modulates courtship and mating. by Jaime Becnel (218896)

5-HT_2C receptor editing in the hippocampus. by Harriët Schellekens (328795)

“…A) Decreased expression of the unedited 5-HT_2C-INI isoform in hippocampus of <i>ob/ob</i> mice, but not statistically significant. …”

Inhibitor of endogenous 5HT synthesis prevents facilitation by oxytocin of FL. by Francesco Dose (540963)

“…On the following day, in both preparations, a stable FL is recorded in the presence of NMDA (5 μM) plus 5HT (10 μM; A, B, left). By decreasing the concentration of neurochemicals, alternating oscillations are replaced by a tonic activity with slow depolarizing events, apparently unrelated among different VRs (A, B, second panels). …”

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. by Narendran Gopalan (110148)

Respiratory network responses to systemic 5-HT_2AR and 5-HT_2BR antagonist applications of in situ rats. by Marcus Niebert (183419)

“…(<b>A</b>) Application of the specific 5-HT_2AR antagonist Altanserin (blue trace) significantly decreased phrenic nerve activity (PNA) by decreasing the amplitude. …”

hESCs-Exo decreased cancer cell proliferation and increased cancer cell death. by Shufeng Zhou (398572)

Bay 61–3606 sensitizes MCF-7 cells to TRAIL by decreasing Mcl-1. by So-Young Kim (562174)

Curcumin induces phosphorylation of p38 MAPK and decreases phosphorylation of Akt in RPE cells. by Margrit Hollborn (394459)

“…As control, PDGF (10 ng/ml) was tested. <b>B.</b> The inhibitor of p38 MAPK activation, SB203580 (SB; 10 µM), decreased the curcumin-induced phosphorylation of p38 MAPK. …”